Review



blocking solution  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Thermo Fisher blocking solution
    Blocking Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Bovine+Serum+Albumin+(BSA)/pm42988017-127-6-56
    Average 99 stars, based on 1 article reviews
    blocking solution - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy ("dying back"): a clinical-neuropathological study.
    Article Snippet: Astrocytes were labeled with anti-glial fibrillary acidic protein (GFAP) antibodies against human (rabbit polyclonal, 1:100; Cat. No. Z0334, lot 00076541, DAKO). .. The primary antibodies were diluted in blocking solution (10% normal goat serum, 0.05% Triton X-100 in phosphate-buffered saline) overnight at 4 °C followed by incubation with goat anti-rabbit Alexa Fluor 488 (1:100; Invitrogen, Carlsbad, CA). .. For CD68 immunostaining, biotin-conjugated goat anti-mouse was used as a secondary antibody; the signal was amplified using a tyramide signal amplification kit (1:250; Invitrogen) following the manufacturer’s instructions [62].

    Article Title: Electroporation as a strategy to improve the efficacy of chemotherapy in neuroblastoma: an in vitro study.
    Article Snippet: .. After PFA quenching with ammonium chloride solution, cells were incubated in blocking solution (1% bovine serum albumin and 0.1% Triton in PBS) for one hour and then incubated with γ-H2AX (S139) antibody (1:100; 3F2; Thermo Fisher Scientific, #MA1-2022) overnight at 4°C. .. Cells were then washed with 0.1% Triton in PBS and incubated with AlexaFluor488 secondary antibody (1:200; Thermo Fisher Scientific, A11006) for four hours at room temperature.

    Article Title: TMEM55B promotes anterograde transport and distal axonal distribution of LAMP1-positive organelles
    Article Snippet: .. For the immunohistochemistry procedure, sections were transferred to 0.1 M PB, incubated in blocking solution (0.5% Triton-X 100 (v/v), 4% normal goat serum (v/v) (Gibco) in 0.1 M PB pH 7.4) for 1 1⁄2 −2 hours and subsequently in the diluted antibody solution (antibodies in blocking solution) overnight at 4 °C. .. The next day, sections were washed with wash solution (0.1 M PB pH 7.4 containing 0.25% Triton-X100) three times for 15 minutes on a shaker, incubated in the secondary antibody solution (AlexaFluor, Molecular Probes/Invitrogen) for 1 1⁄2 hours, washed three times again for 15 minutes in the wash solution, and finally washed in 0.1 M PB pH 7.4 for ten minutes (all steps at room temperature).

    Article Title: A molecularly defined recurrent CA3 circuit regulates network dynamics and spatial working memory
    Article Snippet: .. Fixed slices were incubated in blocking solution (PBS containing 5% normal goat serum and 0.5% Triton X-100) for 2 h at room temperature, followed by incubation with Streptavidin Alexa Fluor 594 (1:500; Invitrogen, S11227) or Streptavidin Alexa Fluor 647 (1:500; Invitrogen, S32357) in incubation solution (PBS containing 0.1% Triton X-100) for 2 days at 4°C. .. Slices were then washed three times in PBS for 10 min per wash and incubated with DAPI (0.5 μg/ml; Invitrogen, D1306) for 20–30 min at room temperature.

    Article Title: Dietary 1,5-anhydro-D-fructose attenuates sarcopenia-related phenotypes: Insights from C. elegans and aged mouse models.
    Article Snippet: Sarcopenia, the age-related loss of skeletal muscle mass and function, represents a major health challenge.. Although 1,5-anhydro-D-fructose (1,5-AF) has been investigated in relation to gut microbiota, oxidative stress, and metabolic disorders, its impact on aging remains unclear.. Here, we evaluated the potential of 1,5-AF as a nutrition-based intervention using cross-species aging models.

    Article Title: Shape-defined poly(lactic acid)-nanohydroxyapatite composite microparticles modulate osteogenic differentiation in 3D microtissues of human mesenchymal stromal cells
    Article Snippet: Microtissues were further lysed in proteinase K (Sigma-Aldrich) overnight at 56 °C, and the DNA content of the lysate was determined using the CyQUANT Cell Proliferation kit, according to the data sheet of the manufacturer. .. After washing with PBS, the microtissues were fixated with 4% v/v FA for 20 min, permeabilized with 0.3% v/v Triton X-100 for 30 min, and their non-specific binding sites were blocked with a blocking solution (5% v/v goat serum and 3% v/v bovine serum albumin in PBS) for 1 h. Samples were incubated with unconjugated rabbit-anti-human recombinant ALP polyclonal primary antibody (1:300, Thermo Fisher Scientific) and unconjugated mouse-anti-human osteopontin (OPN) monoclonal primary antibody (1:200, Thermo Fisher Scientific) at 4 °C overnight. ..

    Article Title: A hypothalamic circuit for anticipating future changes in energy balance.
    Article Snippet: .. Next, we incubated the sections with the primary antibody (Rat anti-mCherry, Invitrogen #M11217, 1:500) diluted in modified blocking solution (PBS with 10% Triton X-100, 5% normal horse serum and 300mM NaCl) in a 37◦C incubator on a shaker for 4 days. .. Sections were washed overnight at RT in PBS + 0.2% Triton X-100 before being incubated in the secondary antibody (anti-rat 594, Invitrogen #21209, 1:500) and DAPI in the same blocking solution as above in a 37◦C incubator on a shaker for 4 days.

    Article Title: Depletion of Neurocan in the Prefrontal Cortex Impairs Temporal Order Recognition, Cognitive Flexibility and Perisomatic GABAergic Innervation.
    Article Snippet: The sections were first washed in 120 mM phosphate buffer (PB) at pH 7.2, then permeabilized with PB containing 0.5% Triton X-100 (Sigma, T9284) for 10 min at 37 °C. .. Then sections were blocked with a blocking solution (PB supplemented with 0.3% Triton X-100 and 5% normal goat serum, NGS, Gibco, 16210-064) for 1 h at 37 °C. ..

    Saline:

    Article Title: Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy ("dying back"): a clinical-neuropathological study.
    Article Snippet: Astrocytes were labeled with anti-glial fibrillary acidic protein (GFAP) antibodies against human (rabbit polyclonal, 1:100; Cat. No. Z0334, lot 00076541, DAKO). .. The primary antibodies were diluted in blocking solution (10% normal goat serum, 0.05% Triton X-100 in phosphate-buffered saline) overnight at 4 °C followed by incubation with goat anti-rabbit Alexa Fluor 488 (1:100; Invitrogen, Carlsbad, CA). .. For CD68 immunostaining, biotin-conjugated goat anti-mouse was used as a secondary antibody; the signal was amplified using a tyramide signal amplification kit (1:250; Invitrogen) following the manufacturer’s instructions [62].

    Incubation:

    Article Title: Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy ("dying back"): a clinical-neuropathological study.
    Article Snippet: Astrocytes were labeled with anti-glial fibrillary acidic protein (GFAP) antibodies against human (rabbit polyclonal, 1:100; Cat. No. Z0334, lot 00076541, DAKO). .. The primary antibodies were diluted in blocking solution (10% normal goat serum, 0.05% Triton X-100 in phosphate-buffered saline) overnight at 4 °C followed by incubation with goat anti-rabbit Alexa Fluor 488 (1:100; Invitrogen, Carlsbad, CA). .. For CD68 immunostaining, biotin-conjugated goat anti-mouse was used as a secondary antibody; the signal was amplified using a tyramide signal amplification kit (1:250; Invitrogen) following the manufacturer’s instructions [62].

    Article Title: Electroporation as a strategy to improve the efficacy of chemotherapy in neuroblastoma: an in vitro study.
    Article Snippet: .. After PFA quenching with ammonium chloride solution, cells were incubated in blocking solution (1% bovine serum albumin and 0.1% Triton in PBS) for one hour and then incubated with γ-H2AX (S139) antibody (1:100; 3F2; Thermo Fisher Scientific, #MA1-2022) overnight at 4°C. .. Cells were then washed with 0.1% Triton in PBS and incubated with AlexaFluor488 secondary antibody (1:200; Thermo Fisher Scientific, A11006) for four hours at room temperature.

    Article Title: TMEM55B promotes anterograde transport and distal axonal distribution of LAMP1-positive organelles
    Article Snippet: .. For the immunohistochemistry procedure, sections were transferred to 0.1 M PB, incubated in blocking solution (0.5% Triton-X 100 (v/v), 4% normal goat serum (v/v) (Gibco) in 0.1 M PB pH 7.4) for 1 1⁄2 −2 hours and subsequently in the diluted antibody solution (antibodies in blocking solution) overnight at 4 °C. .. The next day, sections were washed with wash solution (0.1 M PB pH 7.4 containing 0.25% Triton-X100) three times for 15 minutes on a shaker, incubated in the secondary antibody solution (AlexaFluor, Molecular Probes/Invitrogen) for 1 1⁄2 hours, washed three times again for 15 minutes in the wash solution, and finally washed in 0.1 M PB pH 7.4 for ten minutes (all steps at room temperature).

    Article Title: A molecularly defined recurrent CA3 circuit regulates network dynamics and spatial working memory
    Article Snippet: .. Fixed slices were incubated in blocking solution (PBS containing 5% normal goat serum and 0.5% Triton X-100) for 2 h at room temperature, followed by incubation with Streptavidin Alexa Fluor 594 (1:500; Invitrogen, S11227) or Streptavidin Alexa Fluor 647 (1:500; Invitrogen, S32357) in incubation solution (PBS containing 0.1% Triton X-100) for 2 days at 4°C. .. Slices were then washed three times in PBS for 10 min per wash and incubated with DAPI (0.5 μg/ml; Invitrogen, D1306) for 20–30 min at room temperature.

    Article Title: Dietary 1,5-anhydro-D-fructose attenuates sarcopenia-related phenotypes: Insights from C. elegans and aged mouse models.
    Article Snippet: Sarcopenia, the age-related loss of skeletal muscle mass and function, represents a major health challenge.. Although 1,5-anhydro-D-fructose (1,5-AF) has been investigated in relation to gut microbiota, oxidative stress, and metabolic disorders, its impact on aging remains unclear.. Here, we evaluated the potential of 1,5-AF as a nutrition-based intervention using cross-species aging models.

    Article Title: Shape-defined poly(lactic acid)-nanohydroxyapatite composite microparticles modulate osteogenic differentiation in 3D microtissues of human mesenchymal stromal cells
    Article Snippet: Microtissues were further lysed in proteinase K (Sigma-Aldrich) overnight at 56 °C, and the DNA content of the lysate was determined using the CyQUANT Cell Proliferation kit, according to the data sheet of the manufacturer. .. After washing with PBS, the microtissues were fixated with 4% v/v FA for 20 min, permeabilized with 0.3% v/v Triton X-100 for 30 min, and their non-specific binding sites were blocked with a blocking solution (5% v/v goat serum and 3% v/v bovine serum albumin in PBS) for 1 h. Samples were incubated with unconjugated rabbit-anti-human recombinant ALP polyclonal primary antibody (1:300, Thermo Fisher Scientific) and unconjugated mouse-anti-human osteopontin (OPN) monoclonal primary antibody (1:200, Thermo Fisher Scientific) at 4 °C overnight. ..

    Article Title: A hypothalamic circuit for anticipating future changes in energy balance.
    Article Snippet: .. Next, we incubated the sections with the primary antibody (Rat anti-mCherry, Invitrogen #M11217, 1:500) diluted in modified blocking solution (PBS with 10% Triton X-100, 5% normal horse serum and 300mM NaCl) in a 37◦C incubator on a shaker for 4 days. .. Sections were washed overnight at RT in PBS + 0.2% Triton X-100 before being incubated in the secondary antibody (anti-rat 594, Invitrogen #21209, 1:500) and DAPI in the same blocking solution as above in a 37◦C incubator on a shaker for 4 days.

    Immunohistochemistry:

    Article Title: TMEM55B promotes anterograde transport and distal axonal distribution of LAMP1-positive organelles
    Article Snippet: .. For the immunohistochemistry procedure, sections were transferred to 0.1 M PB, incubated in blocking solution (0.5% Triton-X 100 (v/v), 4% normal goat serum (v/v) (Gibco) in 0.1 M PB pH 7.4) for 1 1⁄2 −2 hours and subsequently in the diluted antibody solution (antibodies in blocking solution) overnight at 4 °C. .. The next day, sections were washed with wash solution (0.1 M PB pH 7.4 containing 0.25% Triton-X100) three times for 15 minutes on a shaker, incubated in the secondary antibody solution (AlexaFluor, Molecular Probes/Invitrogen) for 1 1⁄2 hours, washed three times again for 15 minutes in the wash solution, and finally washed in 0.1 M PB pH 7.4 for ten minutes (all steps at room temperature).

    Binding Assay:

    Article Title: Shape-defined poly(lactic acid)-nanohydroxyapatite composite microparticles modulate osteogenic differentiation in 3D microtissues of human mesenchymal stromal cells
    Article Snippet: Microtissues were further lysed in proteinase K (Sigma-Aldrich) overnight at 56 °C, and the DNA content of the lysate was determined using the CyQUANT Cell Proliferation kit, according to the data sheet of the manufacturer. .. After washing with PBS, the microtissues were fixated with 4% v/v FA for 20 min, permeabilized with 0.3% v/v Triton X-100 for 30 min, and their non-specific binding sites were blocked with a blocking solution (5% v/v goat serum and 3% v/v bovine serum albumin in PBS) for 1 h. Samples were incubated with unconjugated rabbit-anti-human recombinant ALP polyclonal primary antibody (1:300, Thermo Fisher Scientific) and unconjugated mouse-anti-human osteopontin (OPN) monoclonal primary antibody (1:200, Thermo Fisher Scientific) at 4 °C overnight. ..

    Recombinant:

    Article Title: Shape-defined poly(lactic acid)-nanohydroxyapatite composite microparticles modulate osteogenic differentiation in 3D microtissues of human mesenchymal stromal cells
    Article Snippet: Microtissues were further lysed in proteinase K (Sigma-Aldrich) overnight at 56 °C, and the DNA content of the lysate was determined using the CyQUANT Cell Proliferation kit, according to the data sheet of the manufacturer. .. After washing with PBS, the microtissues were fixated with 4% v/v FA for 20 min, permeabilized with 0.3% v/v Triton X-100 for 30 min, and their non-specific binding sites were blocked with a blocking solution (5% v/v goat serum and 3% v/v bovine serum albumin in PBS) for 1 h. Samples were incubated with unconjugated rabbit-anti-human recombinant ALP polyclonal primary antibody (1:300, Thermo Fisher Scientific) and unconjugated mouse-anti-human osteopontin (OPN) monoclonal primary antibody (1:200, Thermo Fisher Scientific) at 4 °C overnight. ..

    Modification:

    Article Title: A hypothalamic circuit for anticipating future changes in energy balance.
    Article Snippet: .. Next, we incubated the sections with the primary antibody (Rat anti-mCherry, Invitrogen #M11217, 1:500) diluted in modified blocking solution (PBS with 10% Triton X-100, 5% normal horse serum and 300mM NaCl) in a 37◦C incubator on a shaker for 4 days. .. Sections were washed overnight at RT in PBS + 0.2% Triton X-100 before being incubated in the secondary antibody (anti-rat 594, Invitrogen #21209, 1:500) and DAPI in the same blocking solution as above in a 37◦C incubator on a shaker for 4 days.

    Next-Generation Sequencing:

    Article Title: Depletion of Neurocan in the Prefrontal Cortex Impairs Temporal Order Recognition, Cognitive Flexibility and Perisomatic GABAergic Innervation.
    Article Snippet: The sections were first washed in 120 mM phosphate buffer (PB) at pH 7.2, then permeabilized with PB containing 0.5% Triton X-100 (Sigma, T9284) for 10 min at 37 °C. .. Then sections were blocked with a blocking solution (PB supplemented with 0.3% Triton X-100 and 5% normal goat serum, NGS, Gibco, 16210-064) for 1 h at 37 °C. ..



    Similar Products

    99
    Vector Laboratories horse serum nhs
    Horse Serum Nhs, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Horse+Serum+Blocking+Solution/pm42883015-117-13-16
    Average 99 stars, based on 1 article reviews
    horse serum nhs - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    93
    Advansta advanblock chemi
    Advanblock Chemi, supplied by Advansta, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/AdvanBlock-Chemi+Blocking+Solution/bio_rxiv__64898__2026__11__05__764664-380-4-6
    Average 93 stars, based on 1 article reviews
    advanblock chemi - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    99
    Thermo Fisher blocking solution
    Blocking Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Bovine+Serum+Albumin+(BSA)/pm42988017-127-6-56
    Average 99 stars, based on 1 article reviews
    blocking solution - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec fc receptor fcr blocking solution
    Fc Receptor Fcr Blocking Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/FcR+Blocking+Reagent%2C+human/pmc13771267-123-11-19
    Average 97 stars, based on 1 article reviews
    fc receptor fcr blocking solution - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    99
    Beyotime goat serum blocking solution
    Goat Serum Blocking Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Goat+Serum/pm42970183-164-5-9
    Average 99 stars, based on 1 article reviews
    goat serum blocking solution - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    93
    Biotium 1x fish skin gelatine blocking solution
    1x Fish Skin Gelatine Blocking Solution, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Fish+Gelatin+Blocking+Agent/bio_rxiv__64898__2026__10__26__761693-471-27-34
    Average 93 stars, based on 1 article reviews
    1x fish skin gelatine blocking solution - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Proteintech excess blocking solution
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Excess Blocking Solution, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/CA2+Antibody/pmc13686549-242-23-39
    Average 93 stars, based on 1 article reviews
    excess blocking solution - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    99
    Vector Laboratories horse serum
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Horse Serum, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Horse+Serum+Blocking+Solution/10__1186_slash_s43682___026___00053___7-69-20-24
    Average 99 stars, based on 1 article reviews
    horse serum - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Expression and localization of CA2 in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Expression and localization of CA2 in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Expressing, Analysis, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Biomarker Discovery, Immunohistochemistry, Reverse Transcription Polymerase Chain Reaction

    Correlation analysis between CA2 expression and clinical indicators. (A) Correlation of CA2 levels with SBP. (B) Correlation of CA2 levels with DBP. (C) Correlation of CA2 levels with Fetal Weight. (D) Correlation of CA2 levels with APGAR‐1 min. (E) Correlation of CA2 levels with APGAR‐5 min. (F) Correlation of CA2 levels with Proteinuria. (G) Correlation of CA2 levels with maternal blood creatinine levels before delivery. (H) Correlation of CA2 levels with blood urea levels. (I) Correlation of CA2 levels with ALT. (J) Correlation of CA2 levels with AST. (K) Correlation of CA2 levels with PT levels. (L) Correlation of CA2 levels with APTT. (M) Correlation of CA2 levels with platelet levels. Correlation analyses were performed using Pearson's correlation coefficient. ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Correlation analysis between CA2 expression and clinical indicators. (A) Correlation of CA2 levels with SBP. (B) Correlation of CA2 levels with DBP. (C) Correlation of CA2 levels with Fetal Weight. (D) Correlation of CA2 levels with APGAR‐1 min. (E) Correlation of CA2 levels with APGAR‐5 min. (F) Correlation of CA2 levels with Proteinuria. (G) Correlation of CA2 levels with maternal blood creatinine levels before delivery. (H) Correlation of CA2 levels with blood urea levels. (I) Correlation of CA2 levels with ALT. (J) Correlation of CA2 levels with AST. (K) Correlation of CA2 levels with PT levels. (L) Correlation of CA2 levels with APTT. (M) Correlation of CA2 levels with platelet levels. Correlation analyses were performed using Pearson's correlation coefficient. ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Analysis, Expressing

    Preeclampsia modeling and placental CA2 expression in L‐NAME mouse model. (A) Experimental workflow of the L‐NAME‐induced preeclampsia model. (B) Changes in systolic blood pressure in L‐NAME and CONTROL groups. (C, E) Body weights of fetal mice in L‐NAME and CONTROL groups. (D) Placental efficiency of fetal mice in L‐NAME and CONTROL groups. (H) SFLT‐1 levels of mice in L‐NAME and CONTROL groups. (F) The ratio of urinary albumin and creatine of mice in L‐NAME and CONTROL groups. (G, I) Representative renal and placental stained with hematoxylin & eosin (H&E) in L‐NAME and CONTROL groups. Scale bars: 250 μm. (J) Ratio of palcental labyrinth and junction zone of mice in L‐NAME and CONTROL groups. (K) MRNA expression level of placental CA2 in L‐NAME and CONTROL groups detected by RT‐qPCR. (L) Representative western blot bands for CA2. (M) Protein expression level of placental CA2 in L‐NAME and CONTROL groups detected by Western Blot. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Preeclampsia modeling and placental CA2 expression in L‐NAME mouse model. (A) Experimental workflow of the L‐NAME‐induced preeclampsia model. (B) Changes in systolic blood pressure in L‐NAME and CONTROL groups. (C, E) Body weights of fetal mice in L‐NAME and CONTROL groups. (D) Placental efficiency of fetal mice in L‐NAME and CONTROL groups. (H) SFLT‐1 levels of mice in L‐NAME and CONTROL groups. (F) The ratio of urinary albumin and creatine of mice in L‐NAME and CONTROL groups. (G, I) Representative renal and placental stained with hematoxylin & eosin (H&E) in L‐NAME and CONTROL groups. Scale bars: 250 μm. (J) Ratio of palcental labyrinth and junction zone of mice in L‐NAME and CONTROL groups. (K) MRNA expression level of placental CA2 in L‐NAME and CONTROL groups detected by RT‐qPCR. (L) Representative western blot bands for CA2. (M) Protein expression level of placental CA2 in L‐NAME and CONTROL groups detected by Western Blot. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Expressing, Control, Staining, Quantitative RT-PCR, Western Blot, Reverse Transcription Polymerase Chain Reaction

    Effects of CA2 on trophoblast cell function. (A) RT‐qPCR analysis to detect the expression of mRNA level after overexpression of CA2 in HTR‐8/SVneo cells. (B) Representative western blot bands for CA2. (C) Western Blot analysis to detect the expression of protein level after overexpression of CA2 in HTR‐8/SVneo cells. (D) Effect of CA2 overexpression on the proliferative capacity of HTR‐8/SVneo cells. (E) Impact of CA2 overexpression on the migration and invasion abilities of HTR‐8/SVneo cells. (F) Statistical analysis of the Transwell migration and invasion assays. (G) Effect of CA2 overexpression on the apoptotic properties of HTR‐8/SVneo cells. (H) Statistical analysis of the apoptosis assay. pEX‐3‐control: Empty vector control group; pEX‐3‐CA2: CA2 overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Effects of CA2 on trophoblast cell function. (A) RT‐qPCR analysis to detect the expression of mRNA level after overexpression of CA2 in HTR‐8/SVneo cells. (B) Representative western blot bands for CA2. (C) Western Blot analysis to detect the expression of protein level after overexpression of CA2 in HTR‐8/SVneo cells. (D) Effect of CA2 overexpression on the proliferative capacity of HTR‐8/SVneo cells. (E) Impact of CA2 overexpression on the migration and invasion abilities of HTR‐8/SVneo cells. (F) Statistical analysis of the Transwell migration and invasion assays. (G) Effect of CA2 overexpression on the apoptotic properties of HTR‐8/SVneo cells. (H) Statistical analysis of the apoptosis assay. pEX‐3‐control: Empty vector control group; pEX‐3‐CA2: CA2 overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Cell Function Assay, Quantitative RT-PCR, Analysis, Expressing, Over Expression, Western Blot, Migration, Apoptosis Assay, Control, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction

    VEGFA overexpression rescues the impaired proliferation, migration and invasion of HTR‐8/SVneo cells induced by CA2 overexpression. (A) Heatmap showing hierarchical clustering of differentially expressed genes between the control and CA2 overexpression groups. (B) Volcano plot of differentially expressed genes. (C) Western Blot analysis of CA2 and VEGFA to detect the protein expression level on the of HTR‐8/SVneo cells in each expremental group. (D) Proliferative capacity analysis of HTR‐8/SVneo cells in the control group、CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (E) Migration and invasion abilities of HTR‐228/SVneo cells in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (F) Statistical analysis of the Transwell migration and invasion abilities in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. pEX‐3‐control 1/2/3: Empty vector control group; pEX‐3‐CA2 1/2/3: CA2 overexpression group; pEX‐3‐control: Empty vector control group; pEX‐3‐ CA2: CA2 overexpression group; pEX‐3‐ CA2+ pEX‐3‐ VEGFA: CA2 and VEGFA co‐overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: VEGFA overexpression rescues the impaired proliferation, migration and invasion of HTR‐8/SVneo cells induced by CA2 overexpression. (A) Heatmap showing hierarchical clustering of differentially expressed genes between the control and CA2 overexpression groups. (B) Volcano plot of differentially expressed genes. (C) Western Blot analysis of CA2 and VEGFA to detect the protein expression level on the of HTR‐8/SVneo cells in each expremental group. (D) Proliferative capacity analysis of HTR‐8/SVneo cells in the control group、CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (E) Migration and invasion abilities of HTR‐228/SVneo cells in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (F) Statistical analysis of the Transwell migration and invasion abilities in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. pEX‐3‐control 1/2/3: Empty vector control group; pEX‐3‐CA2 1/2/3: CA2 overexpression group; pEX‐3‐control: Empty vector control group; pEX‐3‐ CA2: CA2 overexpression group; pEX‐3‐ CA2+ pEX‐3‐ VEGFA: CA2 and VEGFA co‐overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Over Expression, Migration, Control, Western Blot, Analysis, Expressing, Plasmid Preparation

    HIF‐1α activates the transcription of CA2. (A, B) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (C) Representative western blot bands. (D, E) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (F, G) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level after overexpression HIF‐1α in HTR‐8/Svneo cells. (H) Representative western blot bands. (I, J) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level after overexpression HIF‐1α in HTR‐8/Svneo cells. (K) Luciferase activity of HTR‐8/SVneo cells with or without overexpression HIF‐1α. (L) Luciferase activity of HTR‐8/SVneo cells with or without exposing hypoxic environment. pcDNA3.1‐control: Empty vector control group; pcDNA3.1‐HIF‐1α: HIF‐1α overexpression group; CA2 promoter + Vecter: Plasmid with CA2 promoter + empty vector control group; CA2 promoter + HIF‐1α OE: Plasmid with CA2 promoter + HIF‐1α overexpression group; CA2 promoter + Vecter + hypoxia 12 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 12 h; CA2 promoter + Vecter + hypoxia 24 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 24 h; CA2 promoter + Vecter + hypoxia 36 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 36 h. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: HIF‐1α activates the transcription of CA2. (A, B) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (C) Representative western blot bands. (D, E) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (F, G) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level after overexpression HIF‐1α in HTR‐8/Svneo cells. (H) Representative western blot bands. (I, J) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level after overexpression HIF‐1α in HTR‐8/Svneo cells. (K) Luciferase activity of HTR‐8/SVneo cells with or without overexpression HIF‐1α. (L) Luciferase activity of HTR‐8/SVneo cells with or without exposing hypoxic environment. pcDNA3.1‐control: Empty vector control group; pcDNA3.1‐HIF‐1α: HIF‐1α overexpression group; CA2 promoter + Vecter: Plasmid with CA2 promoter + empty vector control group; CA2 promoter + HIF‐1α OE: Plasmid with CA2 promoter + HIF‐1α overexpression group; CA2 promoter + Vecter + hypoxia 12 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 12 h; CA2 promoter + Vecter + hypoxia 24 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 24 h; CA2 promoter + Vecter + hypoxia 36 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 36 h. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Quantitative RT-PCR, Analysis, Expressing, Western Blot, Over Expression, Luciferase, Activity Assay, Control, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction

    Inhibition of CA2 partially improves outcomes in a L‐NAME‐induced PE mouse model. (A) Experimental workflow for LNP‐NC and LNP‐siCA2 treatment in L‐NAME PE mice. (B) MRNA expression level of placental CA2 in LNP‐NC and LNP‐siCA2 groups detected by RT‐qPCR. (C) Representative immunofluorescence staining of CA2 in LNP‐NC and LNP‐siCA2 groups. Scale bars: 500 μm. (D) Quantitative analysis of mean fluorescence intensity of CA2 immunofluorescence signals n LNP‐NC and LNP‐siCA2 groups. (E) Changes in systolic blood pressure in LNP‐NC and LNP‐siCA2 groups. (F) The ratio of urinary albumin and creatine of mice in LNP‐NC group and LNP‐siCA2 group. (G) Representative renal stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. (H) SFLT‐1 levels of mice in LNP‐NC and LNP‐siCA2 groups. (I, K) Body weights of fetal mice in LNP‐NC and LNP‐siCA2 groups. (J) Placental efficiency of fetal mice in LNP‐NC group and LNP‐siCA2 group. (L) Representative placental stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. Scale bars: 250 μm. (M) Ratio of palcental labyrinth and junction zone of mice in LNP‐NC and LNP‐siCA2 groups. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Inhibition of CA2 partially improves outcomes in a L‐NAME‐induced PE mouse model. (A) Experimental workflow for LNP‐NC and LNP‐siCA2 treatment in L‐NAME PE mice. (B) MRNA expression level of placental CA2 in LNP‐NC and LNP‐siCA2 groups detected by RT‐qPCR. (C) Representative immunofluorescence staining of CA2 in LNP‐NC and LNP‐siCA2 groups. Scale bars: 500 μm. (D) Quantitative analysis of mean fluorescence intensity of CA2 immunofluorescence signals n LNP‐NC and LNP‐siCA2 groups. (E) Changes in systolic blood pressure in LNP‐NC and LNP‐siCA2 groups. (F) The ratio of urinary albumin and creatine of mice in LNP‐NC group and LNP‐siCA2 group. (G) Representative renal stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. (H) SFLT‐1 levels of mice in LNP‐NC and LNP‐siCA2 groups. (I, K) Body weights of fetal mice in LNP‐NC and LNP‐siCA2 groups. (J) Placental efficiency of fetal mice in LNP‐NC group and LNP‐siCA2 group. (L) Representative placental stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. Scale bars: 250 μm. (M) Ratio of palcental labyrinth and junction zone of mice in LNP‐NC and LNP‐siCA2 groups. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Inhibition, Expressing, Quantitative RT-PCR, Immunofluorescence, Staining, Analysis, Fluorescence, Reverse Transcription Polymerase Chain Reaction